DTIL - Precision BioSciences, Inc. -  [ ]

Ticker Details
Precision BioSciences, Inc.
IPO Date: May 25, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $91.23M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.24 | 3.65%
Avg Daily Range (30 D): $0.11 | 2.89%
Avg Daily Range (90 D): $0.18 | 3.42%
Institutional Daily Volume
Avg Daily Volume: .14M
Avg Daily Volume (30 D): .18M
Avg Daily Volume (90 D): .21M
Trade Size
Avg Trade Size (Sh.): 41
Avg Trade Size (Sh.) (30 D): 95
Avg Trade Size (Sh.) (90 D): 100
Institutional Trades
Total Institutional Trades: 325
Avg Institutional Trade: $1.41M
Avg Institutional Trade (30 D): $1.65M
Avg Institutional Trade (90 D): $.95M
Avg Institutional Trade Volume: .01M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.55M
Avg Closing Trade (30 D): $1.65M
Avg Closing Trade (90 D): $1.65M
Avg Closing Volume: 9.07K
 
News
Jan 22, 2026 @ 9:56 AM
Genome Editing Market Forecast to Reach $23.6 Bill...
Source: Researchandmarkets.Com
Mar 5, 2025 @ 6:00 PM
CAR T-cell Therapy Clinical Trial Pipeline Experie...
Source: Delveinsight
Sep 10, 2024 @ 9:00 AM
Global Genetic Engineering Market Size To Worth US...
Source: Spherical Insights & Consulting
Sep 10, 2024 @ 8:51 AM
Gene Editing Therapeutics Market Forecast 2024-202...
Source: Researchandmarkets.Com
May 29, 2024 @ 1:55 PM
Does Precision BioSciences (DTIL) Have the Potenti...
Source: Zacks Equity Research
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $-8.99 $-1.84 $-2.13
Diluted EPS $-8.91 $-1.84 $-2.13
Revenue $.7M $.01M $.02M
Gross Profit
Net Income / Loss $-83.6M $-21.77M $-23.52M
Operating Income / Loss $-89.5M $-20.67M $-21.88M
Cost of Revenue
Net Cash Flow $-50.12M $-13.59M $-14.98M
PE Ratio    
Splits
Feb 14, 2024 1:30